Primary Immunodeficiency Disease (PID) Severity Assessment

Assesses primary immunodeficiency severity across B-cell (agammaglobulinemia, CVID), T-cell (SCID, DiGeorge), combined, and phagocyte defects to guide IVIG dosing, HSCT timing, and prophylactic antimicrobial regimens.